Journal scan

Recurrent depression and use of antidepressants linked to lower bone density in men

Major depressive disorder and the use of antidepressants is associated with lower bone density in men, a study in Australia has revealed.

Both depression and antidepressants have been negatively associated with bone mineral density (BMD), but mainly in studies among post-menopausal women. The new study investigated the association in men, using data from the Geelong Osteoporosis Study, a large ongoing population-based study in Australia.

Antidepressant use for recurrent major depressive episodes should be considered a potential risk factor for osteoporosis

Picture credit: Getty

Between 2006 and 2011, 928 men aged 24-98 years completed a comprehensive questionnaire and had BMD assessments at the forearm, spine, total hip and total body. Major depressive disorder was identified using a structured clinical interview.

Recurrent major depressive disorder was associated with lower BMD at the forearm and total body (-6.5% and -2.5% respectively, compared to men with no history of major depressive disorder), while single episodes of major depression were associated with higher BMD at the total hip (+3.4%). Antidepressant use was also associated with lower BMD, but only in lower-weight men.

The researchers conclude that recurrent major depressive disorder may increase the risk of osteoporosis in men, and that antidepressant use should be taken into account as a potential risk factor for osteoporosis, especially in lower-weight men.

This article is for subscribers only